Amorepacific Corporation

Pacific Corporation

Hyun Ju Koh

Won Seok Park

Jin Kyu Choi

Sun-Young Kim

Song Seok Shin

Jin Kwan Kim

Kyung Min Lim

Yeon Su Jeong

Byoung Young Woo

Young-Ger Suh

Ki-Wha Lee

Uh Taek Oh

Joo Hyun Moh

Young-Ho Park

Hyuk Hwan Kim

Dong Hyun Kim

Do-Hoon Kim

Jeong-Hwan Kim

Jong Hee Park

Hong-Ju Shin

Pil Joon Park

Hee-Doo Kim

Hyeung-Geun Park

Joo-Hyun Moh

Su Na Kim

Hyoung Jun Kim

Chang-Geun Yi

Seol Rin Park

Yeonjoon Kim

Hyoung-Jun Kim

Han Bit Kim

Jeongho Lee

Jeong Hwan Kim

Mi Na Jang

Young Ho Park

Duck Hee Kim

Jun Seong Park

Nok Hyun Park

Yung Hyup Joo

Kang-Yell Choi

Miyoung Park

Jee Woo Lee

Shin Chung

Hyeung Geun Park

Joon Ho Bae

Jung Bum Yi

Young Ger Suh

Hee Doo Kim

Hong Ju Shin

Soung-Hoon Lee

Jung A Seo

Jung Sun Hwang

Dae Hyuk Kweon

Shin Young Park

Sung-Il Kim

Ju-Yong Yoon

Kyoung Min Lim

Ok Hui Park

Joo Hyun Kim

Sung-II Kim

Sun Hye Yu

Dae-Jin Min

Jeong Hoon Yoon

Funan Li

Jee-Suk Kim

Sun Young Kim

Young Im Oh

Sa-Yong Hong

Sung Il Kim

Yong-Sil Lee

Chong Hyon Ryu

Yong Sil Lee

Shin Shinchang Missionhill Chung

Song Seok Sk Apt 102-2003 Shin

Kyoung Min Byeokjeoggol Lim

Byoung Young Chamsolmaeul World Meridian Woo

Joo-Hyun Amorepacific Moh

Disclosed is a composition containing an active ingredient or ingredients comprising an extract or extracts of one or more constituents selected from the group consisting of, rose, rhubarb,and cortex. The composition is efficacious in suppressing acneiform pigment deposition and/or pitted scars, and can be used to advantage in various ways in the fields of cosmetics, foods and drugs.

Composition containing a natural extract

Disclosed is herein a composition comprising hexamidines, derivatives thereof, or pharmaceutically acceptable salts thereof; and retinoids, derivatives thereof, or pharmaceutically acceptable salts thereof, as an active ingredient. The composition of the present invention has effects for preventing, improving or treating acne; controlling sebum; pore-controlling; and preventing, improving or treating skin pigmentation. Also, the composition of the present invention could alleviate skin-irritations caused with retinoids by including ceramides.

Composition for skin improvement comprising hexamidines and retinoids

The present disclosure provides a composition for external application to the skin for skin care after laser treatment, which containsextract as an active ingredient. The composition for external application to the skin according to the present disclosure has skin-soothing, skin barrier-recovering and pain-relieving effects and, therefore, can be developed into a cosmetic composition having additional effects of protecting sensitive skin, preventing skin sensitivity, providing skin stability and moisturizing the skin.

[object Object]

The present invention relates to a cosmetic composition containing aextract as an active ingredient, and more particularly to a cosmetic composition containing an extract fromprocessed by traditional oriental medicinal processing technology, in which theextract has an excellent effect of reducing skin wrinkles by inhibiting the formation of SNARE complexes and the release of a neurotransmitter. The cosmetic composition has excellent stability in formulations compared to conventional products for reducing skin wrinkles and exhibit effects similar to Botox which has been used to reduce skin wrinkles, thereby greatly reducing skin wrinkles without causing adverse effects.

Cosmetic compositoin containing a rubus coreanus extract for diminishing skin wrinkles

Provided is a composition for preventing hair loss or promoting hair growth including valproic acid or a pharmaceutically acceptable salt thereof as an active ingredient. The composition may be applied to various industrial fields, including pharmaceutical, cosmetic and beauty aid industries.

Composition for preventing hair loss or for stimulating hair growth

Disclosed is a composition for preventing or treating poliosis or vitiligo comprising agenus plant extract or puerarin as an active ingredient.

This present invention relates to novel compounds, isomer thereof or pharmaceutically acceptable salts thereof as vanilloid receptor (Vanilloid Receptor 1; VR1; TRPV1) antagonist; and a pharmaceutical composition containing the same. The present invention provides a pharmaceutical composition for preventing or treating a disease such as pain, migraine, arthralgia, neuralgia, neuropathies, nerve injury, skin disorder, urinary bladder hypersensitiveness, irritable bowel syndrome, fecal urgency, a respiratory disorder, irritation of skin, eye or mucous membrane, stomach-duodenal ulcer, inflammatory diseases, ear disease, heart disease and so on.

Compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist and pharmaceutical compositions containing the same

The present invention relates to novel thiourea derivatives as a modulator for vanilloid receptor (VR) and the pharmaceutical compositions containing the same. As diseases associated with the activity of vanilloid receptor, pain acute pain, chronic pain, neuropathic pain, post-operative pain, migraine, arthralgia, neuropathies, nerve injury, diabetic neuropathy, neurodegeneration, neurotic skin disorder, stroke, urinary bladder hypersensitiveness, irritable bowel syndrome, a respiratory disorder such as asthma or chronic obstructive pulmonary disease, irritation of skin, eye or mucous membrane, fervescence, stomach-duodenal ulcer, inflammatory bowel disease and inflammatory diseases can be enumerated. The present invention provides a pharmaceutical composition for prevention or treatment of these diseases.

Thiourea derivatives and the pharmaceutical compositions containing the same

2-cyclopenten-1-one oxime derivatives represented by Formula (I), or pharmaceutically acceptable salts thereof inhibit the production of TNF-&#x3b1; or PDE4, and therefore show therapeutic effect in inflammatory or immunological disorders mediated through TNF-&#x3b1; or PDE4.

2-cyclopenten-1-one oxime derivatives inhibiting production of TNF-&#x3b1;

This present invention relates to novel compounds, isomer thereof or pharmaceutically acceptable salts thereof as vanilloid receptor (Vanilloid Receptor 1; VR1; TRPV1) antagonist; and a pharmaceutical composition containing the same. The present invention provides a pharmaceutical composition for preventing or treating a disease such as pain, migraine, arthralgia, neuralgia, neuropathies, nerve injury, skin disorder, urinary bladder hypersensitiveness, irritable bowel syndrome, fecal urgency, a respiratory disorder, irritation of skin, eye or mucous membrane, stomach-duodenal ulcer, inflammatory diseases, ear disease, and heart disease.

Compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same

This present invention relates to novel compounds, isomer thereof or pharmaceutically acceptable salt thereof as vanilloid receptor (Vanilloid Receptor 1; VR1; TRRPV1) antagonist; and a pharmaceutical composition containing the same. The present invention provides a pharmaceutical composition for preventing or treating a disease such as pain, migraine, arthralgia, neuralgia, neuropathies, nerve injury, skin disorder, urinary bladder hypersensitiveness, irritable bowel syndrome, fecal urgency, a respiratory disorder, irritation of skin, eye or mucous membrane, stomach-duodenal ulcer, inflammatory diseases, ear disease, and heart disease.

Growing community of inventors

Anyang-si, South Korea

Hyun Ju Koh